首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells

Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells

Yi-Ting Hu Zhe-Yue Shu Jing-Hua Jiang Qin-Fen Xie Shu-Sen Zheng

国际肝胆胰疾病杂志（英文版）2020，Vol.19Issue(6)：547-554,8.

Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells

Yi-Ting Hu ¹Zhe-Yue Shu ²Jing-Hua Jiang ³Qin-Fen Xie ¹Shu-Sen Zheng¹

作者信息

1. Department of Hepatobiliary and Pancreatic Surgery,Shulan(Hangzhou)Hospital,Zhejiang Shuren University,Shulan International Medical College,Hangzhou 310022,China
2. Division of Hepatobiliary Pancreatic Surgery,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China c Department of Hepatobiliary and Pancreati
3. Surgery,Jinhua Municipal Central Hospital,Jinhua 321000,China
折叠

摘要

关键词

Torin2/Sorafenib resistance/Hepatocellular carcinoma/mTORC2-AKT-BAD pathway

Key words

Torin2/Sorafenib resistance/Hepatocellular carcinoma/mTORC2-AKT-BAD pathway

引用本文复制引用

Yi-Ting Hu,Zhe-Yue Shu,Jing-Hua Jiang,Qin-Fen Xie,Shu-Sen Zheng..Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carcinoma cells[J].国际肝胆胰疾病杂志（英文版）,2020,19(6):547-554,8.

基金项目

This study was supported by a grant from Medical and Health Science and Technology Program of Zhejiang Province(2019RC076). （2019RC076）

国际肝胆胰疾病杂志（英文版）

OACSCDSCI

ISSN：1499-3872

访问量0

下载量0

段落导航